Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Accumulated Depreciation & Amortization (2022 - 2025)

Historic Accumulated Depreciation & Amortization for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $666717.0.

  • bioAffinity Technologies' Accumulated Depreciation & Amortization rose 3511.45% to $666717.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $666717.0, marking a year-over-year increase of 3511.45%. This contributed to the annual value of $536251.0 for FY2024, which is 4371.96% up from last year.
  • As of Q3 2025, bioAffinity Technologies' Accumulated Depreciation & Amortization stood at $666717.0, which was up 3511.45% from $624481.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Accumulated Depreciation & Amortization ranged from a high of $666717.0 in Q3 2025 and a low of $800.0 during Q3 2022
  • Moreover, its 4-year median value for Accumulated Depreciation & Amortization was $412730.0 (2024), whereas its average is $411458.2.
  • In the last 5 years, bioAffinity Technologies' Accumulated Depreciation & Amortization surged by 4189500.0% in 2023 and then soared by 3511.45% in 2025.
  • bioAffinity Technologies' Accumulated Depreciation & Amortization (Quarter) stood at $269180.0 in 2022, then surged by 38.61% to $373123.0 in 2023, then skyrocketed by 43.72% to $536251.0 in 2024, then rose by 24.33% to $666717.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $666717.0 for Q3 2025, versus $624481.0 for Q2 2025 and $580012.0 for Q1 2025.